(Q41591509)

4 October 2017

1 reference

title

Polymeric controlled delivery for immunization (English)

1 reference

4 October 2017

Kuntz RM

1

1 reference

4 October 2017

Saltzman WM

series ordinal

2

1 reference

4 October 2017

publication date

1 September 1997

1 reference

4 October 2017

published in

Trends in Biotechnology

1 reference

4 October 2017

volume

15

1 reference

4 October 2017

issue

9

1 reference

4 October 2017

page(s)

364-369

1 reference

Properties and behavior of orally administered attenuated poliovirus vaccine

4 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2897%2901087-1

7 January 2021

Polymers for the sustained release of proteins and other macromolecules

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2897%2901087-1

7 January 2021

Controlled release of proteins to tissue transplants for the treatment of neurodegenerative disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2897%2901087-1

7 January 2021

Prevention of HIV-2 and SIVsm infection by passive immunization in cynomolgus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2897%2901087-1

7 January 2021

Transport rates of proteins in porous materials with known microgeometry

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2897%2901087-1

7 January 2021

Controlled antibody delivery systems

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2897%2901087-1

7 January 2021

Controlled delivery systems for proteins based on poly(lactic/glycolic acid) microspheres

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2897%2901087-1

7 January 2021

Poly (DL-lactide-co-glycolide) microspheres as carriers for peptide vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2897%2901087-1

7 January 2021

Biodegradable and biocompatible poly(DL-lactide-co-glycolide) microspheres as an adjuvant for staphylococcal enterotoxin B toxoid which enhances the level of toxin-neutralizing antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2897%2901087-1

7 January 2021

Passive immunization of the vagina protects mice against vaginal transmission of genital herpes infections

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2897%2901087-1

7 January 2021

Contraceptive effect of sperm-agglutinating monoclonal antibodies in rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2897%2901087-1

7 January 2021

Mouse sperm antigens that participate in fertilization. III. Passive immunization with a single monoclonal antisperm antibody inhibits pregnancy and fertilization in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2897%2901087-1

7 January 2021

Controlled vaginal delivery of antibodies in the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2897%2901087-1

7 January 2021

Residence half-life of IgG administered topically to the mouse vagina

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2897%2901087-1

7 January 2021

Controlled release of antibodies for long-term topical passive immunoprotection of female mice against genital herpes

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2897%2901087-1

7 January 2021

A single-step immunization by sustained antigen release

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2897%2901087-1

7 January 2021

Single-step immunization using a controlled release, biodegradable polymer with sustained adjuvant activity

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2897%2901087-1

7 January 2021

Biodegradable microspheres as controlled-release tetanus toxoid delivery systems.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2897%2901087-1

7 January 2021

Adjuvant effect of biodegradable poly(DL-lactic acid) granules capable for antigen release following intraperitoneal injection

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2897%2901087-1

7 January 2021

Development of a single-shot subunit vaccine for HIV-1. 3. Effect of adjuvant and immunization schedule on the duration of the humoral immune response to recombinant MN gp120.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2897%2901087-1

7 January 2021

Activation patterns of murine T cells after oral administration of an enterocoated soluble antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2897%2901087-1

7 January 2021

Activation patterns of murine B cells after oral administration of an encapsulated soluble antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2897%2901087-1

7 January 2021

Protection against vaginal SIV transmission with microencapsulated vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2897%2901087-1

7 January 2021

Oral immunization with an anti-idiotypic antibody to the exoglycolipid antigen protects against experimental Chlamydia trachomatis infection

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2897%2901087-1

7 January 2021

Vaccines to prevent viral hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2897%2901087-1

7 January 2021

Generation and assembly of secretory antibodies in plants

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2897%2901087-1

7 January 2021

Oral immunization with a recombinant bacterial antigen produced in transgenic plants.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2897%2901087-1

7 January 2021

Exploring transgenic plants as a new vaccine source

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2897%2901087-1

7 January 2021

10.1016/S0167-7799(97)01087-1

Identifiers

DOI

1 reference

4 October 2017

1 reference